Search results

Page results

• Trial of innovative blood cancer treatment expanded

  A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.

• Robotic Bilateral Salpingo-oophorectomy

  This information aims to help answer some of the questions that you may have about having a robotic bilateral salpingo-oophorectomy (removal of tubes and ovaries).

• Good luck in the TCS London Marathon, UCLH Charity runners!

  The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.

• Study sheds light on accidental awareness during pregnancy-related surgery and how to prevent it

  Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.

• Women’s mental agility is better during menstruation

  Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).

• Series No 5 - Molecular Radiotherapy for adults having radioactive iodine (131I) treatment

  This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.

• Omnipod 5 Update

  We are very excited that the Omnipod 5 has now been launched. The team have been busy over the last few months getting training and ensuring that the pump is on our procurement system.

• Getting to Grips with Anxiety - Two-part online workshop

  This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• App detecting neonatal jaundice from the eye successful in first major clinical trial

  A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.